ALPS Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,354
Closed -$832K 967
2019
Q4
$832K Sell
4,354
-305
-7% -$55K 0.01% 377
2019
Q3
$784K Sell
4,659
-2,279
-33% -$371K 0.01% 349
2019
Q2
$1.16M Buy
6,938
+292
+4% +$40.4K 0.01% 296
2019
Q1
$973K Buy
+6,646
New +$964K 0.01% 334
2018
Q3
Sell
-5,304
Closed -$884K 1116
2018
Q2
$884K Buy
+5,304
New +$852K 0.01% 359
2017
Q1
Sell
-1,042
Closed -$219K 869
2016
Q4
$219K Buy
+1,042
New +$216K ﹤0.01% 692

Other funds holding AGN

ALPS Advisors's AGN Position: Q1 2020 in Review

ALPS Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 4,354 shares — an estimated $832K sold.

ALPS Advisors first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $1.16M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • ALPS Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • ALPS Advisors sold 4,354 Allergan plc shares in Q1 2020, an estimated $832K.
  • ALPS Advisors first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • ALPS Advisors's Allergan plc position peaked at $1.16M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on ALPS Advisors's 13F filing for Q1 2020, filed 6 May 2020.